Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Why BHC Stock surged +28.76% Today — RQD Quant Desk Flash
Bausch Health Companies Inc. (BHC) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (62/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+232.3% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Why BHC Stock surged +28.76% Today — RQD Quant Desk Flash
Bausch Health Companies Inc. (BHC) surged +28.76% to $8.91 as options desks priced 72% call premium vs. 28% put protection around the $9 max-pain magnet. Accounting Warning: Paper earnings outpaced operating cash flow (+232.3% (NI vs OCF)) as receivables rose.
- ▸Technical Tape: Trading at 97% of its 52-week range ($4.33 – $9.04) with RSI-14 at 72.3 (OVERBOUGHT (>70)).
- ▸Whale Options Positioning: $3.3M in bullish call flow vs. $1.2M in put flow (Put/Call 0.38x, implied earnings swing ±6.8%).
- ▸Primary SEC / Cross-Feed Trigger: BHC Accounting Gap: Net Income (+220%) Outpaced OCF (-12.3%) With +-1.1% Working-Capital Build
2026-10-30. The following slide deck was published by Bausch Health Companies Inc.
US session market movers: NUBURU led gainers at 125.0% while GameStop's GME.W fell 48.11% among the biggest losers.
Jefferies analyst Young Li maintains Bausch Health Companies (NYSE:BHC) with a Hold and raises the price target from $6.5 to $8.
RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price target from $9 to $10.
Bausch Health shares jump 9% as Q3 earnings top estimates, driven by Xifaxan-led Salix growth, improved profitability and raised 2026 guidance.
Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc Health
Moby summary of Bausch Health Companies Inc.'s Q3 2026 earnings call
Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.
Bausch Health Companies Inc. (BHC) Q3 2026 Earnings Call October 28, 2026 5:00 PM EDTCompany ParticipantsGaren SarafianThomas Appio - CEO &...
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring BHC)
- ✓Live walkthrough of BHC's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
BHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BHC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BHC. Explore sector supply chains on /butterfly.
BHC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BHC stock moving today?
Why BHC Stock surged +28.76% Today — RQD Quant Desk Flash. Accounting Warning: Paper earnings outpaced operating cash flow (+232.3% (NI vs OCF)) as receivables rose.